Literature DB >> 21877303

[Cannabinoid hyperemesis syndrome inducing acute prerenal failure and electrolyte disturbance].

J Bramstedt1, R Dissmann.   

Abstract

HISTORY AND CLINICAL
FINDINGS: A 36-year-old patient presented to the psychiatric clinic with presumed worsening of a chronic psychosis. INVESTIGATIONS: Laboratory values revealed acute renal failure and electrolyte imbalance. A further diagnostic work-up including urine analysis as well as abdominal und retroperitoneal sonography was normal. DIAGNOSIS, THERAPY AND CLINICAL COURSE: By exact history taking the clinical diagnosis of a cannabinoid hyperemesis syndrome (CHS) was established. Symptomatic treatment with intravenous fluids and electrolytes together with strict cannabis abstinence completely resolved all symptoms and normalized all pathologic values.
CONCLUSION: Recreational use of cannabis is widespread. It may induce a widely unknown syndrome characterized by nausea, vomiting and crampy abdominal pain accompanied by frequent hot showers or bathing. This syndrome should be recognized as a potential cause of acute prerenal failure. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21877303     DOI: 10.1055/s-0031-1286065

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  4 in total

1.  Evidence of Misclassification of Drug-Event Associations Classified as Gold Standard 'Negative Controls' by the Observational Medical Outcomes Partnership (OMOP).

Authors:  Manfred Hauben; Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2016-05       Impact factor: 5.606

Review 2.  Cannabinoid hyperemesis syndrome: a guide for the practising clinician.

Authors:  Sanjin Bajgoric; Kiran Samra; Subashini Chandrapalan; Nishant Gautam
Journal:  BMJ Case Rep       Date:  2015-12-23

Review 3.  A Review of Cannabis in Chronic Kidney Disease Symptom Management.

Authors:  Claudia Ho; Dan Martinusen; Clifford Lo
Journal:  Can J Kidney Health Dis       Date:  2019-02-22

Review 4.  The nephrologist's guide to cannabis and cannabinoids.

Authors:  Joshua L Rein
Journal:  Curr Opin Nephrol Hypertens       Date:  2020-03       Impact factor: 3.416

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.